Valuation Edwards Lifesciences Corporation
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 86.07 USD | -0.98% |
|
+4.16% | +0.96% |
Company Valuation: Edwards Lifesciences Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 80,883 | 46,128 | 46,246 | 43,663 | 49,471 | 49,559 | - | - |
| Change | - | -42.97% | 0.25% | -5.58% | 13.3% | 0.18% | - | - |
| Enterprise Value (EV) 1 | 80,616 | 45,956 | 45,198 | 40,285 | 45,843 | 46,063 | 44,550 | 42,784 |
| Change | - | -42.99% | -1.65% | -10.87% | 13.8% | 0.48% | -3.29% | -3.96% |
| P/E | 54.4x | 30.6x | 33.2x | 10.6x | 46.6x | 34x | 26.1x | 23.2x |
| PBR | 13.9x | 7.82x | 6.99x | 4.36x | 4.79x | 4.72x | 4.09x | 3.8x |
| PEG | - | 12.14x | -5.79x | 0x | -0.6x | 0.9x | 0.9x | 1.8x |
| Capitalization / Revenue | 15.5x | 8.57x | 7.7x | 8.03x | 8.15x | 7.33x | 6.67x | 6.06x |
| EV / Revenue | 15.4x | 8.54x | 7.53x | 7.41x | 7.56x | 6.81x | 6x | 5.23x |
| EV / EBITDA | 46.6x | 23.7x | 24.1x | 24.1x | 25.5x | 21.6x | 18.7x | 15.9x |
| EV / EBIT | 50.6x | 25.6x | 26.1x | 26.6x | 27.9x | 23.4x | 20.1x | 17.2x |
| EV / FCF | 57.3x | 47.2x | 47.9x | 139x | 34.3x | 54.3x | 27.7x | 23.5x |
| FCF Yield | 1.74% | 2.12% | 2.09% | 0.72% | 2.91% | 1.84% | 3.61% | 4.25% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 2.38 | 2.44 | 2.3 | 6.97 | 1.83 | 2.531 | 3.303 | 3.718 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 5,232 | 5,382 | 6,005 | 5,440 | 6,068 | 6,759 | 7,429 | 8,177 |
| EBITDA 1 | 1,729 | 1,936 | 1,879 | 1,670 | 1,800 | 2,137 | 2,383 | 2,687 |
| EBIT 1 | 1,594 | 1,796 | 1,734 | 1,514 | 1,644 | 1,971 | 2,212 | 2,484 |
| Net income 1 | 1,503 | 1,522 | 1,402 | 4,175 | 1,074 | 1,435 | 1,895 | 2,120 |
| Net Debt 1 | -267 | -172.7 | -1,048 | -3,378 | -3,628 | -3,496 | -5,010 | -6,776 |
| Reference price 2 | 129.55 | 74.61 | 76.25 | 74.03 | 85.25 | 86.07 | 86.07 | 86.07 |
| Nbr of stocks (in thousands) | 624,334 | 618,260 | 606,500 | 589,800 | 580,300 | 575,800 | - | - |
| Announcement Date | 1/26/22 A | 1/31/23 A | 2/6/24 A | 2/11/25 A | 2/10/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 34.01x | 6.81x | 21.56x | -.--% | 49.56B | ||
| 28.64x | 5.12x | 19.64x | 0.32% | 213B | ||
| 32.54x | 5.97x | 18.9x | 0.75% | 137B | ||
| 38.77x | 10.04x | 22.2x | -.--% | 125B | ||
| 17.36x | 3.69x | 11.98x | -.--% | 69.46B | ||
| 19.02x | 2.23x | 11.28x | 2.68% | 47.2B | ||
| 26.91x | 5.36x | 18.3x | 0.74% | 39.08B | ||
| 45.73x | 6.38x | 19.6x | -.--% | 37.05B | ||
| 14.61x | 1.69x | 9.45x | 0.23% | 30.72B | ||
| 42.65x | 6.78x | 23.98x | -.--% | 31.03B | ||
| Average | 30.02x | 5.41x | 17.69x | 0.47% | 77.94B | |
| Weighted average by Cap. | 30.43x | 5.87x | 18.56x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- EW Stock
- Valuation Edwards Lifesciences Corporation
Select your edition
All financial news and data tailored to specific country editions
















